In this work, MUC1 aptamer could specifically target MUC1 protein overexpressed on cancer cell membranes and the sequence of T22‐NLS peptide could bind affinity with CXC chemokine receptor (CXCR4). This evidence concerns the gene MUC1 and cancer.